[Therapeutic effects and mechanism of action of S-adenosyl-L-methionine (SAM) in depressive syndromes].
D000275:Adjustment Disorders / Q000188:drug therapy; D000311:Adrenal Glands / Q000378:metabolism; D000328:Adult; D000368:Aged; D000818:Animals; D001714:Bipolar Disorder / Q000188:drug therapy*; D001921:Brain / Q000378:metabolism; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D003865:Major Depressive Disorder / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008099:Liver / Q000378:metabolism; D008168:Lung / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009206:Myocardium / Q000378:metabolism; D012436:S-Adenosylmethionine / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*
D012436:S-Adenosylmethionine
Effetti terapeutici e meccanismo d'azione della S-adenosil-L-metionina (SAM) nelle sindromi depressive.